日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors

替莫唑胺和甲氧胺(TRC-102,一种碱基切除修复抑制剂)治疗晚期实体瘤患者的I期临床试验

Eads, Jennifer R; Krishnamurthi, Smitha S; Saltzman, Joel; Bokar, Joseph A; Savvides, Panos; Meropol, Neal J; Gibbons, Joseph; Koon, Henry; Sharma, Neelesh; Rogers, Lisa; Pink, John J; Xu, Yan; Beumer, Jan H; Riendeau, John; Fu, Pingfu; Gerson, Stanton L; Dowlati, Afshin

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

舒尼替尼联合吉西他滨治疗晚期实体瘤患者的I期临床试验

Brell, Joanna M; Krishnamurthi, Smitha S; Rath, Linda; Bokar, Joseph A; Savvides, Panayiotis; Gibbons, Joseph; Cooney, Matthew M; Meropol, Neal J; Ivy, Percy; Dowlati, Afshin

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

一项针对难治性实体瘤患者的瑞贝卡霉素类似物联合奥沙利铂的I期研究

Nock, Charles J; Brell, Joanna M; Bokar, Joseph A; Cooney, Matthew M; Cooper, Brenda; Gibbons, Joseph; Krishnamurthi, Smitha; Manda, Sudhir; Savvides, Panayiotis; Remick, Scot C; Ivy, Percy; Dowlati, Afshin

A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.

fosbretablin 治疗晚期未分化甲状腺癌的 II 期试验以及基线血清可溶性细胞间粘附分子-1 与结果的相关性

Mooney Colin J, Nagaiah Govardhanan, Fu Pingfu, Wasman Jay K, Cooney Matthew M, Savvides Panos S, Bokar Joseph A, Dowlati Afshin, Wang Ding, Agarwala Sanjiv S, Flick Susan M, Hartman Paul H, Ortiz Jose D, Lavertu Pierre N, Remick Scot C

Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

多西他赛和沙利度胺的I期临床试验:基于节拍治疗原则的治疗方案

Sanborn, Sharon L; Cooney, Matthew M; Dowlati, Afshin; Brell, Joanna M; Krishnamurthi, Smitha; Gibbons, Joseph; Bokar, Joseph A; Nock, Charles; Ness, Anne; Remick, Scot C